Cxbladder is a Genomic Urine Test Optimized for the Detection and Management of Bladder Cancer

Cxbladder is a non-invasive genomic urine test that quickly and accurately detects or rules out bladder cancer in patients presenting with hematuria and those monitoring for recurrence. The test, which comes with the option of in-home sampling, combines clinical risk factor markers with genetic information, measuring five biomarker genes to detect the presence or absence of bladder cancer.

I'm a physician: I'd like to learn more

Cxbladder Benefits

Reliable: Cxbladder utilizes high sensitivity and negative predictive value to either help rule out the disease or complement other diagnostic procedures and tests to improve overall detection accuracy.

Clinically proven: Proven performance in 12 peer-reviewed publications for primary detection, surveillance, and adjudicating atypical cytology. Cxbladder is used by over 1,800 urologists in more than 40,000 patients.

Non-invasive and easy-to-use: Cxbladder’s unique urine sample collection system is discrete, non-invasive and easy-to-use, taking only minutes.

In-home sampling: To streamline patient care we are now offering an in-home sampling service to both hematuria and surveillance patients.

Quick: Upon receiving a urine sample, our certified US laboratory will provide actionable results in 7 days.

Download our Clinician Brochure

A Suite of Tests Optimized for Primary Detection and Surveillance

Cxbladder comes as a family of three products each optimized for a specific point along the patient journey.

Cxbladder Triage:

Designed for patients presenting with hematuria, Cxbladder Triage analyzes the presence of five biomarker genes alongside information on known bladder cancer risk factors like age, gender and smoking history to rule out patients with a low risk of having the disease, reducing the need for further invasive procedures.

Cxbladder Detect

In cases where a patient is symptomatic and bladder cancer looks likely, Cxbladder Detect can help confirm your diagnosis. By detecting and quantifying signs of cancer at the molecular level, Cxbladder Detect outperforms other urine-based tests, making it an ideal choice for bladder cancer testing when patients present with significant symptoms. Cxbladder Detect can also be used as an adjunct to cystoscopy or as a substitute for other radiological tests to improve overall detection accuracy.

Cxbladder Monitor

Developed specifically for patients undergoing surveillance for recurrent bladder cancer, Cxbladder Monitor combines clinical information linked to previous bladder cancer with measured biomarker genes to help rule out the presence of a recurrent tumour, or to indicate that further clinical investigation is required.

Cxbladder Monitor can provide accurate results with a single urine sample, and test is often used as a non-invasive monitoring alternative to reduce the frequency of cystoscopy required.

Download our Clinician Brochure

In-home Sampling is Now Available

Cxbladder’s unique urine sampling system is non-invasive and easy-to-use. The process is quick and painless, taking only minutes.

To simplify and streamline the bladder cancer testing process, we are now offering in-home sampling for both hematuria and surveillance patients. Participating patients have the option of submitting their urine sample in the comfort of their own home without the need to physically visit their Urologist.

Medicare Now Covers Cxbladder

We’re pleased to confirm that Cxbladder is now covered by Medicare.

For questions about coverage please call the Cxbladder Assist Team at 1-855-CXBLADR (1-855-292-5237, option 1).

The Difference in Cancer Detection

Cxbladder is a reliable test for bladder cancer that can help you make informed treatment and care decisions. Contact us today to learn more.

Phone: 1-855-CXBLADR (1-855-292-5237)
Email: us.info@cxbladder.com